In the US, Mibefradil is a member of the drug class calcium channel blocking agents and is used to treat Angina and High Blood Pressure.
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C08CX01
CAS registry number (Chemical Abstracts Service)
0116644-53-2
Chemical Formula
C29-H38-F-N3-O3
Molecular Weight
495
Therapeutic Categories
Vasodilator
Calcium channel blocker
Chemical Name
Acetic acid, methoxy-,2-[2-[[3-(1H-benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, (1S-cis)-
Foreign Names
- Mibefradilum (Latin)
- Mibefradil (German)
- Mibefradil (French)
- Mibefradil (Spanish)
Generic Names
- Mibefradil (OS: BAN)
- Mibefradil Dihydrochloride (OS: USAN)
- Mibefradil Hydrochloride (OS: BANM)
- Ro 40-5967/001 (IS: Roche)
Brand Names
- Posicor
Roche, Argentina; Roche, Bangladesh
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment